Ovarian Cancer: Navigating the Challenges of Late Diagnosis, Biomarker Limitations, and Tumor Heterogeneity
Ovarian Cancer: Navigating the Challenges of Late Diagnosis, Biomarker Limitations, and Tumor Heterogeneity Ovarian cancer remains one of the most lethal gynaecologic malignancies, with a five-year survival rate of only ~50% for advanced-stage cases. Despite advances in treatment, significant challenges persist late diagnosis, inefficient biomarkers, and extreme tumour heterogeneity, each contributing to poor outcomes. Among […]